Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression
about
Citalopram versus other anti-depressive agents for depressionSelective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential AnalysisLack of effect of a single dose of ketoconazole on the pharmacokinetics of citalopram.Efficacy and safety of generic escitalopram versus Lexapro in the treatment of major depression: a multicenter double-blinded randomized controlled trialAntidepressants in the management of cancer pain.Extrapyramidal symptoms and antidepressant drugs: neuropharmacological aspects of a frequent interaction in the elderly.Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic reviewAre typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder.Nicotinic acetylcholine receptors as targets for antidepressants.Escitalopram.Citalopram in children and adolescents with depression or anxiety.Serotonergic drugs in the treatment of depressive and anxiety disorders.SSRI versus bupropion effects on symptom clusters in suicidal depression: post hoc analysis of a randomized clinical trialHomeopathic Individualized Q-Potencies versus Fluoxetine for Moderate to Severe Depression: Double-Blind, Randomized Non-Inferiority TrialAnimal models of depression: are there any?Drug effects on salivary glands: dry mouth.Clinical Guidelines on Long-Term Pharmacotherapy for Bipolar Disorder in Children and AdolescentsA review of antidepressant-induced hypomania in major depression: suggestions for DSM-V.Adverse drug reactions in the orofacial region.Dose-response relationship of recent antidepressants in the short-term treatment of depression.Citalopram and suicidality in adult major depression and anxiety disorders.Duloxetine in the treatment of major depressive disorder.Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder.Does study design influence outcome?. The effects of placebo control and treatment duration in antidepressant trials.Less is more in antidepressant clinical trials: a meta-analysis of the effect of visit frequency on treatment response and dropout.Bio-sample preparation and analytical methods for the determination of tricyclic antidepressants.Citalopram for major depressive disorder in adults: a systematic review and meta-analysis of published placebo-controlled trials.Problems in the Descriptions of the Psychiatric Inclusion and Exclusion Criteria in Publications of Antidepressant Efficacy Trials: A Qualitative Review and Recommendations for Improved Clarity.Phantom limb pain treatment with mirtazapine: a case series.Patient Expectancy as a Mediator of Placebo Effects in Antidepressant Clinical Trials.Multiple possible inaccuracies cast doubt on a recent report suggesting selective serotonin reuptake inhibitors to be toxic and ineffective.Does elimination of placebo responders in a placebo run-in increase the treatment effect in randomized clinical trials? A meta-analytic evaluation.Citalopram Ameliorates Impairments in Spatial Memory and Synaptic Plasticity in Female 3xTgAD MiceLack of citalopram effect on oral digoxin pharmacokinetics.Central and peripheral anti-inflammatory effects of maprotiline on carrageenan-induced paw edema in rats.Ondansetron rather than metoclopramide for bupropion-induced nausea.Dysthymic disorder: treatment with citalopram.Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.Naturalistic study of the early psychiatric use of citalopram in the United States.Biofeedback assisted control of respiratory sinus arrhythmia as a biobehavioral intervention for depressive symptoms in patients after cardiac surgery: a preliminary study.
P2860
Q24202141-4B305D1D-7D67-421D-967A-DFFF56F090C1Q28736049-1C7F24DC-0F4F-4DB2-BC42-292C916EA2F9Q32049831-E202E119-C849-48AE-B152-3EF906CF4ACEQ33744405-6C80395E-2553-4ABE-A2DA-3ED73115D9C3Q34222796-91C43FD3-D893-4CFB-81AA-2733998C36F3Q34228583-5B45C75C-64F5-4AA1-A6EF-44BC4061F3C1Q34240696-DE96F904-DF4F-4DAF-A794-139EB1DDE74AQ34617592-36E06333-83C4-4942-B4E0-6DDFBC2DEC0EQ34761238-73FDF98B-5918-4CC4-8CDD-1E5C5085C80EQ34974884-50397C15-DDB0-46DC-A535-70ACB17AA3BDQ34979657-99382F82-BCB1-489B-B8EE-E890CCCE81BDQ34982492-AF63738A-CF7F-4771-904E-BAAA84EB275DQ35036979-20F3612B-16E7-46BD-9061-ED56D5FD0EC0Q35105942-DE977E33-F587-4994-A5E5-E6659713CD2BQ35136039-D58560E7-6206-474A-B18B-BBD8393C8FBBQ35219131-D895CC81-CE89-49B2-9DE8-30418FAE6956Q35667205-53517BA5-4533-4E56-922E-B1A5846EED47Q35680384-04E2897D-2351-4915-9966-C580B5E7453DQ35850842-635559DB-140B-4A16-9713-61D3AE0ACEE5Q36255130-7A9688C8-91E1-41ED-8DA9-7D3A160AB877Q36622342-1E553F2F-6582-49D1-A896-949EEA8A405FQ37125752-8EEAAE61-6113-4763-9F37-6E4D90082BA7Q37156421-D95F1A0A-C86C-4586-A14C-6E34A5E0FE37Q37202188-DC405774-133A-4F26-842F-F39C73A31159Q37503551-91AE1FA8-8BA8-4E1E-BF19-913A7F5C7005Q37822787-70F59C87-D9F0-4255-8499-3B99342B6411Q37948756-1AF35D2E-49E5-44B4-BCF5-FF191255E260Q38714376-CECB389F-9A74-4B9C-8F13-E0886793A35CQ39342051-E28FBE54-537A-46C9-823A-C829F99F4A6AQ39409071-00E4D29F-558F-405F-8323-517BBCC95E4BQ39441213-86F918FE-DCA1-4777-ABFA-5D583E7A1371Q40529963-3C89D1B5-9B0C-4E64-A0A5-F021535AFABAQ42556970-1603BC14-1323-413C-8999-62AD441AE631Q42645848-61044209-7FE6-42B5-8E1D-18767F475C12Q43007010-1E776D62-D391-44F0-9FF0-F4BCBCD0C1D4Q43626950-096020B9-28D5-4EDB-8F58-12306F116594Q43869839-F2D5546F-F304-4469-BEC4-DC2C36934DD6Q44119946-1E320CBC-775E-4A3C-BEC9-CADAF59E645FQ44204378-D00BE882-7A53-4AE7-9DF4-638A8432A9D0Q44844942-F5647D05-90EB-4FE3-A93E-7BB003C22E3B
P2860
Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Multicenter, placebo-controlle ...... moderate-to-severe depression
@ast
Multicenter, placebo-controlle ...... moderate-to-severe depression
@en
Multicenter, placebo-controlle ...... moderate-to-severe depression
@nl
type
label
Multicenter, placebo-controlle ...... moderate-to-severe depression
@ast
Multicenter, placebo-controlle ...... moderate-to-severe depression
@en
Multicenter, placebo-controlle ...... moderate-to-severe depression
@nl
prefLabel
Multicenter, placebo-controlle ...... moderate-to-severe depression
@ast
Multicenter, placebo-controlle ...... moderate-to-severe depression
@en
Multicenter, placebo-controlle ...... moderate-to-severe depression
@nl
P356
P1476
Multicenter, placebo-controlle ...... moderate-to-severe depression
@en
P2093
P304
P356
10.4088/JCP.V60N1204
P407
P577
1999-12-01T00:00:00Z